修正药业集团长春高新制药有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
74
NMPA:74
Drug Approvals
Dapoxetine Hydrochloride Tablets
- Product Name
- 盐酸达泊西汀片
- Approval Number
- 国药准字H20254300
- Approval Date
- May 27, 2025
NMPA
Moxifloxacin Hydrochloride Eye Drops
- Product Name
- 盐酸莫西沙星滴眼液
- Approval Number
- 国药准字H20244254
- Approval Date
- Jun 28, 2024
NMPA
Sildenafil Citrate Tablets
- Product Name
- 枸橼酸西地那非片
- Approval Number
- 国药准字H20233341
- Approval Date
- Mar 24, 2023
NMPA
Terbinafine Hydrochloride Tablets
- Product Name
- 盐酸特比萘芬片
- Approval Number
- 国药准字H20083816
- Approval Date
- Nov 7, 2022
NMPA
Hydrotalcite Chewable Tablets
- Product Name
- 铝碳酸镁咀嚼片
- Approval Number
- 国药准字H20065569
- Approval Date
- Dec 21, 2020
NMPA
Naphazoline Hydrochloride,Chlorphenamine Maleate and Vitamin B12 Eye Drops
- Product Name
- 萘敏维滴眼液
- Approval Number
- 国药准字H20067796
- Approval Date
- Nov 20, 2020
NMPA
- Prev
- 1
- 2
- 3
- 4
- 5
- 8
- Next
Clinical Trials
No trials found
News
No news found